# Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS

> **NCT00308425** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 119 (actual)

## Conditions studied

- De Novo Renal Transplantation

## Interventions

- **DRUG:** Enteric-coated Mycophenolate sodium (EC-MPS), valsartan

## Key facts

- **NCT ID:** NCT00308425
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2011-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308425, "Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00308425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*